Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 8;9(3):ofab618.
doi: 10.1093/ofid/ofab618. eCollection 2022 Mar.

Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic

Katharine Uhteg  1 , Adannaya Amadi  2 , Michael Forman  2 , Heba H Mostafa  2
Affiliations

Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic

Katharine Uhteg et al. Open Forum Infect Dis. .

Abstract

Background: Our understanding of the cocirculation of infrequently targeted respiratory pathogens and their contribution to symptoms during the coronavirus disease 2019 (COVID-19) pandemic is currently limited. This research aims at (1) understanding the epidemiology of respiratory pathogens since the start of the pandemic, (2) assessing the contribution of non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/influenza/respiratory syncytial virus (RSV) respiratory pathogens to symptoms, and (3) evaluating coinfection rates in SARS-CoV-2-positive patients, both vaccinated and unvaccinated.

Methods: Retrospective analysis of respiratory pathogens identified by the Johns Hopkins Diagnostic Laboratory between December 2019 and October 2021 was performed. In addition, we assessed the contribution of respiratory pathogens other than SARS-CoV-2 to symptomatic disease by retesting 2 cohorts of specimens that were (1) collected from symptomatic patients and (2) received limited respiratory pathogen testing. The first cohort was patients who tested negative by the standard-of-care SARS-CoV-2/influenza/RSV testing. The second was a cohort of SARS-CoV-2-positive, symptomatic, fully COVID-19 immunized and unimmunized patients.

Results: Between December 2019 and October 2021, a total of 11 806, 62 829, and 579 666 specimens were tested for an extended respiratory panel, influenza/RSV with or without SARS-CoV-2 panel, or SARS-CoV-2, respectively. Positivity rates of different targets differed between different months and were impacted by the COVID-19 pandemic. The SARS-CoV-2-negative cohort had 8.5% positivity for other respiratory pathogens that included primarily enterovirus/rhinovirus (5.8%). In the SARS-CoV-2-positive cohort, no other respiratory pathogens were detected.

Conclusions: The COVID-19 pandemic impacted the circulation of certain respiratory pathogens. Other respiratory viral pathogens were associated with symptomatic infections; however, coinfections with SARS-CoV-2 were highly uncommon.

Keywords: COVID-19; SARS-CoV-2; coinfections.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Respiratory virus positivity rates from December 2019 to October 2021. Total numbers tested and positive tests for each target are detailed in Supplementary Table S1. HMPV, human metapneumovirus; HPIV, human parainfluenza virus; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SARS-CoV-2 (Symp), indicates symptomatic testing positivity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Solomon DA, Sherman AC, Kanjilal S.. Influenza in the COVID-19 era. JAMA 2020; 324:1342–3. - PubMed
    1. Mostafa HH, Carroll KC, Hicken R, et al. . Multi-center evaluation of the cepheid Xpert (R) Xpress SARS-CoV-2/Flu/RSV test. J Clin Microbiol 2020. doi:10.1128/JCM.02955-20. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Testing guidance for clinicians when SARS-CoV-2 and influenza viruses are co-circulating. Available at: https://www.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-cli.... Accessed 7 February 2022.
    1. Uyeki TM, Bernstein HH, Bradley JS, et al. . Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis 2018; 68:e1–47. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2 (COVID-19). Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html. Accessed 7 February 2022.